| Literature DB >> 35711903 |
Guangtao Bai1, Liang Jiang2, Sai Huan3, Pingping Meng1, Yuyang Wang1, Xiaona Pan1, Shuai Yin1, Yuyang Zhao1, Qiang Wang1.
Abstract
Objective: To explore the therapeutic effect and mechanism of low-frequency repetitive transcranial magnetic stimulation on the speech function of patients with non-fluent aphasia after stroke.Entities:
Keywords: BDNF; TNF-α; aphasia; functional magnetic resonance; repetitive transcranial magnetic stimulation
Year: 2022 PMID: 35711903 PMCID: PMC9197107 DOI: 10.3389/fnagi.2022.883542
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.702
General information of the enrolled patients.
| rTMS group | S-rTMS group | |
| Number of cases | 30 | 30 |
| Clinical scale measurement (pre/post) | 30/30 | 30/28 |
| Serum factor determination (pre/post) | 30/28 | 30/24 |
| fMRI (pre/post) | 16/13 | 12/10 |
| Gender: (Male: Female) | 17:13 | 14:16 |
| Course of disease (months, | 3.27 ± 1.50 | 3.75 ± 1.67 |
| Age (years, | 63.47 ± 7.81 | 59.91 ± 8.58 |
| Aphasia quotient-pre | 28.16 ± 22.86 | 22.76 ± 18.81 |
| Stroke type (hemorrhagic: infarct: mixed) group | 13: 15: 2 | 16: 13: 1 |
Evaluation results and statistical analysis of the clinical scale for the two groups of patients.
| rTMS (30) | S-rTMS (28) | |||
| Pre | Post | Pre | Post | |
| Spontaneous language | 5.10 ± 5.03 | 9.93 ± 5.24 | 3.73 ± 4.22 | 6.68 ± 4.46 |
| Listening comprehension | 3.51 ± 2.50 | 5.86 ± 2.79 | 3.13 ± 2.34 | 4.69 ± 2.46 |
| Repetition | 3.21 ± 2.83 | 5.56 ± 3.04 | 2.69 ± 2.52 | 3.97 ± 2.91 |
| Naming | 2.26 ± 2.41 | 4.96 ± 2.49 | 1.86 ± 2.11 | 3.39 ± 2.17 |
| Aphasia quotient | 28.16 ± 22.86 | 52.62 ± 25.02 | 22.76 ± 18.81 | 37.46 ± 20.51 |
| Short-form Token Test | 12.77 ± 8.41 | 20.90 ± 9.97 | 11.17 ± 8.13 | 17.57 ± 9.19 |
*There is a statistical difference in the comparison before and after treatment within the group, P < 0.05.
FIGURE 1fALFF analysis of the difference between the two groups before and after treatment. The blue area is the brain area where activation is inhibited (threshold: individual level P < 0.05, clump level P < 0.05).
FIGURE 2DC analysis of the distribution of brain regions with significant differences between the two groups before and after treatment, the yellow area is the activated brain area (threshold: individual level P < 0.05, clump level P < 0.05).
FIGURE 3Select ROI function connection pairwise comparison function connection diagram (p < 0.05).
Comparison statistical scores of serum BDNF levels before and after treatment in the two groups.
| Number pre/post | Pre-BDNF (pg/ml) | Post-BDNF (pg/ml) | ||
| rTMS group | 30/28 | 35.34 ± 5.53 | 42.09 ± 9.16 | 0.0116 |
| S-rTMS group | 30/24 | 31.14 ± 9.27 | 34.76 ± 8.79 | 0.4326 |
| 0.2541 | 0.0077 |